Edition:
United Kingdom

Sellas Life Sciences Group Inc (SLS.OQ)

SLS.OQ on NASDAQ Stock Exchange Capital Market

1.60USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$1.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
232,025
52-wk High
$11.08
52-wk Low
$0.80

Chart for

About

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunothera... (more)

Overall

Beta: 2.02
Market Cap(Mil.): $15.70
Shares Outstanding(Mil.): 38.41
Dividend: --
Yield (%): --

Financials

  SLS.OQ Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -0.86 -- --
ROI: -59.58 15.55 14.96
ROE: -79.40 16.92 16.52

Earnings vs. Estimates